Low-Level Laser Therapy in Androgenetic Alopecia: Narrative Review

    March 2023 in “ Medical lasers
    Hyun Seok Ryu, Byong-Taek Lee, Andrew Padalhin, Phil-Sang Chung, Seung Hoon Woo
    TLDR Low-level laser therapy is a safe and effective treatment for hair loss.
    The narrative review on low-level laser therapy (LLLT) for androgenetic alopecia (AGA) discusses various studies and trials that have explored the efficacy of LLLT in promoting hair growth. The review highlights that LLLT, using devices such as helmets and combs emitting red light, has shown promising results in both men and women with AGA. Multiple randomized, double-blind, sham device-controlled trials, including those with durations of 16 to 24 weeks, have demonstrated significant improvements in hair density and thickness. The review also notes that combining LLLT with other treatments like minoxidil can enhance outcomes. Overall, LLLT is presented as a safe and effective option for managing AGA, with minimal side effects reported.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    6 / 1000+ results

      research Female Pattern Hair Loss: An Update

      12 citations, January 2020 in “Indian Dermatology Online Journal”
      Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.